Human myeloid leukemia cells metabolize 25-hydroxyvitamin D3invitro
- 1 March 1985
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 127 (2), 635-641
- https://doi.org/10.1016/s0006-291x(85)80208-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Sarcoid granulomas metabolize 25-hydroxyvitamin D3invitroBiochemical and Biophysical Research Communications, 1984
- 1α,25-Dihyroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytesBiochemical and Biophysical Research Communications, 1983
- 19-Nor-10-ketovitamin D derivatives: unique metabolites of vitamin D3, vitamin D2, and 25-hydroxyvitamin D3Biochemistry, 1983
- CONTROL OF MACROPHAGE CELL-DIFFERENTIATION IN HUMAN PROMYELOCYTIC HL-60 LEUKEMIA-CELLS BY 1,25-DIHYDROXYVITAMIN-D3 AND PHORBOL-12-MYRISTATE-13-ACETATE1983
- ESTABLISHMENT OF DIFFERENT CLONAL STRAINS FROM A HUMAN SARCOMA OF THE STOMACH - TUMORIGENIC HETEROGENEITY IN ATHYMIC NUDE-MICE1983
- Rodent macrophages metabolize 25-hydroxyvitamin D3in, vitroBiochemical and Biophysical Research Communications, 1982
- Studies on the mechanism of action of 1α,24-dihydroxyvitamin D3 III the specific binding of 1α,24-dihydroxyvitamin D3 to the receptor of chick parathyroid glandSteroids, 1982
- Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3.Proceedings of the National Academy of Sciences, 1981
- Metabolism and Mechanism of Action of Vitamin DAnnual Review of Biochemistry, 1976
- THE STORY OF VITAMIN D FROM VITAMIN TO HORMONEThe Lancet, 1974